SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON
The reason for the Systemic Anti-Cancer Therapy Drug Regimen upfront dose modification.
Format / Length
an1
Description
National Codes
| Code | Description |
|---|---|
| 1 |
PATIENT choice |
| 2 |
ORGANISATION (Trust) issues |
| 3 |
PATIENT (Clinical) factors |
| 4 | Toxicity |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON |